Journal
IMMUNITY & AGEING
Volume 12, Issue -, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/s12979-015-0054-8
Keywords
BPIFB4; Methylat on; CD34; Vascular ageing
Categories
Funding
- Italian Ministry of University and Research [AUTOMED - RBAP11Z3YA, PB05]
- Italian Ministry of Health [2010 2302354]
- ITALBIONET (Italian Bioinformatics Network)
Ask authors/readers for more resources
Background: People that reach extreme ages (Long-Living Individuals, LLIs) are object of intense investigation for increase/decrease of genetic variant frequencies, genetic methylation levels, protein abundance in serum and tissues. The aim of these studies is the discovery of the mechanisms behind LLIs extreme longevity and the identification of markers of well-being. We have recently associated a BPIFB4 haplotype (LAV) with exceptional longevity under a homozygous genetic model, and identified that CD34T of LLIs subjects express higher BPIFB4 transcript as compared to CD34(+) of control population. It would be of interest to correlate serum BPIFB4 protein levels with exceptional longevity and health status of LLIs. Methods: Western blots on cellular medium to detect BPIFB4 secretion in transfected HEK293T cells with plasmic carrying BPIFB4 and ELISA on LLIs serum to detect BPIFB4 levels. Results: Here we show that BPIFB4 is a secreted protein and its levels are increased in serum of LLIs, and high BPIFB4 levels classify their health status. Conclusions: Serum BPIFB4 protein levels classify longevity and health status in LLIs. Further studies are required to evaluate the possible role of BPIFB4 in monitoring disease progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available